Gastrointestinal Cancer
From the Journals
Oncologists Voice Ethical Concerns Over AI in Cancer Care
Researchers ask 204 oncologists from 37 states for their views on the ethical implications of using AI for cancer care.
From the Journals
Further Support for CRC Screening to Start at Age 45: Meta-Analysis
Across 15 studies, 41,709 adenomas were detected in 150,436 colonoscopies performed for any indication, resulting in a pooled overall ADR of 23.1...
Feature
What to Know About the Next-Gen FIT for CRC Screening
These multitarget approaches take the standard FIT a step further by testing for additional DNA, RNA, or protein biomarkers associated with CRC to...
Conference Coverage
Circulating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive Cancers
New study results suggest ctDNA dynamics provide an early window into predicting response to targeted therapies in patients with HER2-altered...
Conference Coverage
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Cancer
Researchers develop signature for pancreatic cancer based on microRNAs and cell-free DNA markers in the blood of patients with the disease.
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
From the Journals
Less Than 50% of Accelerated Approvals Show Clinical Benefit
Researchers review 46 cancer drugs granted accelerated approvals between 2013 and 2017.
Conference Coverage
Combo Therapy Prolongs Survival in Gastric Cancer Patients, Regardless of PD-L1 Expression
Researchers evaluate the efficacy and safety of first-line cadonilimab plus standard chemotherapy in patients with advanced or metastatic gastric...
News from the FDA/CDC
FDA Expands Enhertu Indication to HER2-Positive Solid Tumors
The agent had already been approved for several cancer types.
From the Journals
New Quality Measure Improves Follow-Up for CRC Screening
Field testing shows that this CRC screening tracker is “feasible, valid, and reliable.”
From the Journals
Eliminating H pylori Lowers CRC Incidence, Mortality Risk
Investigators review CRC incidence and mortality in a nationwide cohort of veterans tested for H pylori.